Oppenheimer raised the firm’s price target on UnitedHealth (UNH) to $640 from $610 and keeps an Outperform rating on the shares. The firm updated its model based solely on the published numbers issued to the public in an 8-K as a result of the suspension of the company’s suspended investor conference, the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Gunman of UnitedHealth (UNH) CEO Shooting Left a Chilling Message on Ammo
- UnitedHealth price target raised to $675 from $605 at Stephens
- Salesforce up after Q3, GM outlines $5B in China business charges: Morning Buzz
- UnitedHealth ‘deeply saddened’ by passing of UnitedHealthcare CEO Thompson
- UnitedHealth says working closely with NYPD